TMCnet - World's Largest Communications and Technology Community



Research and Markets: Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014
[June 11, 2014]

Research and Markets: Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vancoycin-Resistant Enterococcus Faecium Infections and special features on late-stage and discontinued projects.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Exploit Technologies Pte Ltd
  • Piramal Enterprises Limited
  • Aphios Corporation
  • Wockhardt Limited
  • Paratek Pharmaceuticals, Inc.
  • Alchemia Limited
  • Immtech Pharmaceuticals, Inc.
  • Lorus Therapeutics Inc.
  • NovaBay Pharmaceuticals, Inc.
  • Oragenics, Inc.
  • Microbio Co., Ltd.
  • MicuRx Pharmaceuticals, Inc.
  • Enanta Pharmaceuticals, Inc.
  • TAXIS Pharmaceuticals, Inc.
  • LegoChem Biosciences, Inc
  • MGB Biopharma Limited
  • Sentinella Pharmaceuticals, Inc.
  • Sealife PHARMA GMBH

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy